Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel Therapeutics

作者
Moizza Mansoor,Alirio Jose Melendez
出处
期刊:Gene regulation and systems biology [SAGE]
卷期号:2: 275-95 被引量:114
标识
DOI:10.4137/grsb.s418
摘要

Antisense oligonucleotides (As-ODNs) are single stranded, synthetically prepared strands of deoxynucleotide sequences, usually 18-21 nucleotides in length, complementary to the mRNA sequence of the target gene. As-ODNs are able to selectively bind cognate mRNA sequences by sequence-specific hybridization. This results in cleavage or disablement of the mRNA and, thus, inhibits the expression of the target gene. The specificity of the As approach is based on the probability that, in the human genome, any sequence longer than a minimal number of nucleotides (nt), 13 for RNA and 17 for DNA, normally occurs only once. The potential applications of As-ODNs are numerous because mRNA is ubiquitous and is more accessible to manipulation than DNA. With the publication of the human genome sequence, it has become theoretically possible to inhibit mRNA of almost any gene by As-ODNs, in order to get a better understanding of gene function, investigate its role in disease pathology and to study novel therapeutic targets for the diseases caused by dysregulated gene expression. The conceptual simplicity, the availability of gene sequence information from the human genome, the inexpensive availability of synthetic oligonucleotides and the possibility of rational drug design makes As-ODNs powerful tools for target identification, validation and therapeutic intervention. In this review we discuss the latest developments in antisense oligonucleotide design, delivery, pharmacokinetics and potential side effects, as well as its uses in target identification and validation, and finally focus on the current developments of antisense oligonucleotides in therapeutic intervention in various diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
含蓄傲珊发布了新的文献求助10
2秒前
今后的应助被clyj采纳,获得10
2秒前
脑洞疼的应助被陈鸿超采纳,获得10
2秒前
大模型的应助被PYF8086采纳,获得10
2秒前
qin202569发布了新的文献求助10
2秒前
coco发布了新的文献求助10
2秒前
小二郎的应助被small_LL采纳,获得10
2秒前
2秒前
hdskjahfi发布了新的文献求助10
3秒前
WaNgBO完成签到,获得积分10
3秒前
缙云山2020发布了新的文献求助10
3秒前
3秒前
3秒前
hua发布了新的文献求助10
3秒前
4秒前
清秀的吐司完成签到,获得积分20
4秒前
雨洛完成签到 ,获得积分10
4秒前
杨耑耑完成签到 ,获得积分10
4秒前
所所的应助被来一杯忌廉采纳,获得30
4秒前
daomaihu发布了新的文献求助100
4秒前
lzh完成签到,获得积分20
5秒前
ling完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
7秒前
hk完成签到,获得积分20
7秒前
哼哼完成签到,获得积分10
7秒前
taco发布了新的文献求助10
7秒前
eflower_tea完成签到,获得积分10
8秒前
newnew完成签到 ,获得积分10
8秒前
乾清宫喝奶茶完成签到,获得积分10
8秒前
8秒前
lyn发布了新的文献求助60
8秒前
8秒前
cjs发布了新的文献求助10
9秒前
小马甲的应助被顽石采纳,获得10
9秒前
ZARD发布了新的文献求助10
9秒前
9秒前
Peter发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176174
求助须知:如何正确求助?哪些是违规求助? 9567656
关于积分的说明 21793895
捐赠科研通 7770887
什么是DOI,文献DOI怎么找? 3431991
关于科研通互助平台的介绍 2556313
邀请新用户注册赠送积分活动 2477540